ARCHIVES

Feds Set Guidelines For Pharma To Help Patients With Cost Of Drugs, While Steering Clear Of Anti-Kickback Law.

This article is from The Cancer Letter archive.

Vol. 32 No. 16 | April 28, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: New Greg For Surgery Research Approved; Only 30 Bioassay Program Reports Still In Backlog

April 21, 1978

In Brief: GM Prizes: Einhorn, McMahon, Nusslein-Volhard; James, Poznanski Lead Roentgen Ray Society

June 26, 1992

NCI Advisors Approve New Grant Programs Worth $100 Million

March 27, 2009

Fondaparinux Prevents DVT In Acutely III Medical Patients

January 30, 2004

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

November 20, 1992

CCOP RFA On The Street; Addition Of Cancer Control Research Adds New Dimension To Program

July 18, 1986